205 related articles for article (PubMed ID: 27151546)
1. Medical adherence to topical corticosteroid preparations prescribed for psoriasis: A systematic review.
Svendsen MT; Andersen F; Hansen J; Johannessen H; Andersen KE
J Dermatolog Treat; 2017 Feb; 28(1):32-39. PubMed ID: 27151546
[TBL] [Abstract][Full Text] [Related]
2. Worldwide utilization of topical remedies in treatment of psoriasis: a systematic review.
Svendsen MT; Jeyabalan J; Andersen KE; Andersen F; Johannessen H
J Dermatolog Treat; 2017 Aug; 28(5):374-383. PubMed ID: 27786594
[TBL] [Abstract][Full Text] [Related]
3. Adherence to topical treatment in psoriasis: a systematic literature review.
Devaux S; Castela A; Archier E; Gallini A; Joly P; Misery L; Aractingi S; Aubin F; Bachelez H; Cribier B; Jullien D; Le Maître M; Richard MA; Ortonne JP; Paul C
J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():61-7. PubMed ID: 22512682
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of combinations of first-line topical treatments in chronic plaque psoriasis: a systematic literature review.
Hendriks AG; Keijsers RR; de Jong EM; Seyger MM; van de Kerkhof PC
J Eur Acad Dermatol Venereol; 2013 Aug; 27(8):931-51. PubMed ID: 23279069
[TBL] [Abstract][Full Text] [Related]
5. Treatment adherence and real-life effectiveness of topical therapy in patients with mild or moderate psoriasis: uptake of scientific evidence in clinical practice and dermatologists' preferences for alternative treatment options.
Neri L; Miracapillo A
G Ital Dermatol Venereol; 2015 Feb; 150(1):19-26. PubMed ID: 25521808
[TBL] [Abstract][Full Text] [Related]
6. Are ointments better than other vehicles for corticosteroid treatment of psoriasis?
Zivkovich AH; Feldman SR
J Drugs Dermatol; 2009 Jun; 8(6):570-2. PubMed ID: 19537382
[TBL] [Abstract][Full Text] [Related]
7. eHealth Technologies as an intervention to improve adherence to topical antipsoriatics: a systematic review.
Svendsen MT; Andersen F; Andersen KE
J Dermatolog Treat; 2018 Mar; 29(2):123-128. PubMed ID: 28604138
[TBL] [Abstract][Full Text] [Related]
8. Non-adherence and measures to improve adherence in the topical treatment of psoriasis.
Zschocke I; Mrowietz U; Karakasili E; Reich K
J Eur Acad Dermatol Venereol; 2014 May; 28 Suppl 2():4-9. PubMed ID: 24684738
[TBL] [Abstract][Full Text] [Related]
9. Improving psoriasis patients' adherence to topical drugs: a systematic review.
Svendsen MT; Feldmann S; Tiedemann SN; Sørensen ASS; Rivas CMR; Andersen KE
J Dermatolog Treat; 2020 Dec; 31(8):776-785. PubMed ID: 31122090
[No Abstract] [Full Text] [Related]
10. Nonadherence to psoriasis medication as an outcome of limited coping resources and conflicting goals: findings from a qualitative interview study with people with psoriasis.
Thorneloe RJ; Bundy C; Griffiths CE; Ashcroft DM; Cordingley L
Br J Dermatol; 2017 Mar; 176(3):667-676. PubMed ID: 27664406
[TBL] [Abstract][Full Text] [Related]
11. Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis.
Brown KK; Rehmus WE; Kimball AB
J Am Acad Dermatol; 2006 Oct; 55(4):607-13. PubMed ID: 17010739
[TBL] [Abstract][Full Text] [Related]
12. Poor adherence to medication as assessed by the Morisky Medication Adherence Scale-8 and low satisfaction with treatment in 237 psoriasis patients.
Saeki H; Imafuku S; Abe M; Shintani Y; Onozuka D; Hagihara A; Katoh N; Murota H; Takeuchi S; Sugaya M; Tanioka M; Kaneko S; Masuda K; Hiragun T; Inomata N; Kitami Y; Tsunemi Y; Abe S; Kobayashi M; Morisky DE; Furue M
J Dermatol; 2015 Apr; 42(4):367-72. PubMed ID: 25720544
[TBL] [Abstract][Full Text] [Related]
13. [Adherence of local (and general) treatments in psoriasis].
Cribier B
Ann Dermatol Venereol; 2012 Jan; 139 Suppl 1():S13-7. PubMed ID: 22305281
[TBL] [Abstract][Full Text] [Related]
14. Are topical keratolytic agents needed in the treatment of scalp psoriasis?
Shokeen D; O'Neill JL; Taheri A; Feldman SR
Dermatol Online J; 2014 Mar; 20(3):. PubMed ID: 24656276
[TBL] [Abstract][Full Text] [Related]
15. Long-term adherence to topical psoriasis treatment can be abysmal: a 1-year randomized intervention study using objective electronic adherence monitoring.
Alinia H; Moradi Tuchayi S; Smith JA; Richardson IM; Bahrami N; Jaros SC; Sandoval LF; Farhangian ME; Anderson KL; Huang KE; Feldman SR
Br J Dermatol; 2017 Mar; 176(3):759-764. PubMed ID: 27664969
[TBL] [Abstract][Full Text] [Related]
16. Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy.
Castela E; Archier E; Devaux S; Gallini A; Aractingi S; Cribier B; Jullien D; Aubin F; Bachelez H; Joly P; Le Maître M; Misery L; Richard MA; Paul C; Ortonne JP
J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():47-51. PubMed ID: 22512680
[TBL] [Abstract][Full Text] [Related]
17. Role of personalized medication training in improving efficacy and adherence to a topical therapy in psoriatic patients.
Caldarola G; De Simone C; Moretta G; Poscia A; Peris K
J Dermatolog Treat; 2017 Dec; 28(8):722-725. PubMed ID: 28488449
[TBL] [Abstract][Full Text] [Related]
18. Disease burden and treatment adherence in psoriasis patients.
Feldman SR
Cutis; 2013 Nov; 92(5):258-63. PubMed ID: 24343214
[TBL] [Abstract][Full Text] [Related]
19. Factors impacting the combination of topical corticosteroid therapies for psoriasis: perspectives from the International Psoriasis Council.
van de Kerkhof PC; Kragballe K; Segaert S; Lebwohl M;
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1130-9. PubMed ID: 21564329
[TBL] [Abstract][Full Text] [Related]
20. Canadian Patients' Preferences in Topical Psoriasis Care: Insights From the PROPEL Surveys.
Vender R; Gooderham MJ; Guenther LC; Kyritsis D; Rao J; Kowalczyk A; Ashkenas J
J Cutan Med Surg; 2018; 22(5):464-471. PubMed ID: 29754528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
